Trials / Completed
CompletedNCT02322957
A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers
A Phase 1 Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- ContraVir Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to evaluate the potential for a PK drug-drug interaction between FV-100 and ritonavir. The study is a single-center, open-label, randomized, 2-way crossover design in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FV-100 | Subjects will be randomized to one of two treatment sequences: AB or BA. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-04-01
- Completion
- 2015-07-01
- First posted
- 2014-12-23
- Last updated
- 2015-10-01
Source: ClinicalTrials.gov record NCT02322957. Inclusion in this directory is not an endorsement.